Significant Ownership of Cormorant Asset Management, LP

Notable people
Bihua Chen
Signature - Title
/s/ Bihua Chen - Bihua Chen, Managing Member
Location
Boston, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Cormorant Asset Management, LP.

Notify me when Cormorant Asset Management, LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Cormorant Asset Management, LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CRBP Corbus Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share 13% $24,434,598 -$312,902 2,344,971 -1.3% Cormorant Asset Management, LP 11 Dec 2025
DRUG Bright Minds Biosciences Inc. Common Shares 11% $82,670,191 1,059,331 Cormorant Asset Management, LP 31 Jan 2026
IBIO iBio, Inc. Common Stock, $0.001 par value per share 10% $1,850,337 2,248,010 Cormorant Asset Management, LP 30 Sep 2025
EYPT EyePoint Pharmaceuticals, Inc. Common Stock 10% $99,097,350 8,265,000 Cormorant Asset Management, LP 04 Dec 2025
CABA Cabaletta Bio, Inc. Common Stock, par value $0.00001 per share 9.3% $20,586,000 -$420,443 9,400,000 -2% Cormorant Asset Management, LP 31 Dec 2025
CRGX CARGO Therapeutics, Inc. Common stock, par value $0.001 per share 7.3% $15,655,313 3,381,277 Cormorant Asset Management, LP 31 Mar 2025
RAPP Rapport Therapeutics, Inc. Common Stock, $0.001 par value per share 6.4% $82,045,819 -$4,471,500 3,027,521 -5.2% Cormorant Asset Management, LP 31 Dec 2025
MLTX MoonLake Immunotherapeutics Class A ordinary share, par value $0.0001 per share 6.1% $74,477,904 4,355,433 Cormorant Asset Management, LP 31 Dec 2025
ENGN enGene Holdings Inc. Common Shares 6% $33,520,000 4,000,000 Cormorant Asset Management, LP 31 Dec 2025
BIOA BioAge Labs, Inc. Common Stock, par value $0.00001 per share 5.7% $36,424,799 -$1,785,000 2,040,605 -4.7% Cormorant Asset Management, LP 31 Dec 2025
PRAX Praxis Precision Medicines, Inc. Common Stock, par value $0.0001 per share 4% $53,000,000 -$33,125,000 1,000,000 -38% Cormorant Asset Management, LP 30 Sep 2025
BMEA Biomea Fusion, Inc. Common Stock 1.5% $2,143,436 -$5,295,734 1,060,792 -71% Chen Bihua 22 Oct 2025
KALA KALA BIO, Inc. Common Stock, $0.001 par value per share 0% $0 -$931,568 0 -100% Cormorant Asset Management, LP 30 Sep 2025
VYNE VYNE Therapeutics Inc. Common Stock, par value $0.0001 per share 0% $0 -$459,264 0 -100% Cormorant Asset Management, LP 30 Sep 2025
OKUR OnKure Therapeutics, Inc. Class A Common Stock, par value $0.0001 per share 0% $0 0 Cormorant Asset Management, LP 15 May 2025

Schedules 13D/G Reported by Cormorant Asset Management, LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.